Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation

László Tamás and Kotmayer Lili and Fésüs Viktória and Hegyi Lajos and Gróf Stefánia and Nagy Ákos and Kajtár Béla and Balogh Alexandra and Weisinger Júlia and Masszi Tamás and Nagy Zsolt and Farkas Péter and Demeter Judit and Istenes Ildikó and Szász Róbert and Gergely Lajos and Sulák Adrienn and Borbényi Zita and Lévai Dóra and Schneider Tamás and Pettendi Piroska and Bodai Emese and Szerafin László and Rejtő László and Bátai Árpád and Dömötör Mária Á and Sánta Hermina and Plander Márk and Szendrei Tamás and Hamed Aryan and Andrikovics Hajnalka and Egyed Miklós and Masszi András and Alpár Donát and Matolcsy András and Bödör Csaba: Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.
JOURNAL OF PATHOLOGY: CLINICAL RESEARCH, 10 (1). ISSN 2056-4538 (2024)

Actions (login required)